Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage
NCT02875262Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferoxamine in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
deferoxamine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02875262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875262.